CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review

Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe PRES under CNI therapy shortly after heart transp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katharina Huenges, Philipp Kolat, Bernd Panholzer, Assad Haneya
Formato: article
Lenguaje:EN
Publicado: Georg Thieme Verlag KG 2021
Materias:
Acceso en línea:https://doaj.org/article/6404fb2a242d4da4b5bb9bca7b846e2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6404fb2a242d4da4b5bb9bca7b846e2b
record_format dspace
spelling oai:doaj.org-article:6404fb2a242d4da4b5bb9bca7b846e2b2021-11-11T00:00:03ZCSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review2194-76352194-764310.1055/s-0041-1732344https://doaj.org/article/6404fb2a242d4da4b5bb9bca7b846e2b2021-01-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1732344https://doaj.org/toc/2194-7635https://doaj.org/toc/2194-7643Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe PRES under CNI therapy shortly after heart transplantation is presented here. Cerebral computed tomography led to the diagnose of PRES in our patient. New therapy strategy with a quadruple immunosuppressive protocol (cortisone, mycophenolate mofetil, low-dose CNI, and a mechanistic target of rapamycin inhibitor) was started. Conclusion Under the quadruple therapy, a neurologic recovery occurred. In PRES, the presented alternative therapy strategy may lead to improving neurological conditions and preserved transplant organ functions.Katharina HuengesPhilipp KolatBernd PanholzerAssad HaneyaGeorg Thieme Verlag KGarticleheart transplantationimmunusuppressionrejectionSurgeryRD1-811ENThe Thoracic & Cardiovascular Surgeon Reports, Vol 10, Iss 01, Pp e59-e60 (2021)
institution DOAJ
collection DOAJ
language EN
topic heart transplantation
immunusuppression
rejection
Surgery
RD1-811
spellingShingle heart transplantation
immunusuppression
rejection
Surgery
RD1-811
Katharina Huenges
Philipp Kolat
Bernd Panholzer
Assad Haneya
CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
description Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe PRES under CNI therapy shortly after heart transplantation is presented here. Cerebral computed tomography led to the diagnose of PRES in our patient. New therapy strategy with a quadruple immunosuppressive protocol (cortisone, mycophenolate mofetil, low-dose CNI, and a mechanistic target of rapamycin inhibitor) was started. Conclusion Under the quadruple therapy, a neurologic recovery occurred. In PRES, the presented alternative therapy strategy may lead to improving neurological conditions and preserved transplant organ functions.
format article
author Katharina Huenges
Philipp Kolat
Bernd Panholzer
Assad Haneya
author_facet Katharina Huenges
Philipp Kolat
Bernd Panholzer
Assad Haneya
author_sort Katharina Huenges
title CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
title_short CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
title_full CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
title_fullStr CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
title_full_unstemmed CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review
title_sort csa-induced pres after heart transplantation—report of two cases and review
publisher Georg Thieme Verlag KG
publishDate 2021
url https://doaj.org/article/6404fb2a242d4da4b5bb9bca7b846e2b
work_keys_str_mv AT katharinahuenges csainducedpresafterhearttransplantationreportoftwocasesandreview
AT philippkolat csainducedpresafterhearttransplantationreportoftwocasesandreview
AT berndpanholzer csainducedpresafterhearttransplantationreportoftwocasesandreview
AT assadhaneya csainducedpresafterhearttransplantationreportoftwocasesandreview
_version_ 1718439679031771136